Drug recall D-0579-2023
Product
Heparin Sodium, 25,000 USP units per 250mL, (100 USP units per mL) in 5% Dextrose injection, 250 ml Excel Container, B. Braun Medical Inc. Bethlehem, PA 18018, USA; API from Spain NDC: 0264-9587-20,
Reason for recall
Subpotent: Low anti-factor IIa Potency.
Lots and codes
Lot Number: J1P154N, Exp: 31 May, 2023,
Recall details
- Recalling firm
- B. Braun Medical Inc, Irvine, CA
- Quantity
- 1,380
- Distribution
- Nationwide in the USA
- Type
- Voluntary: Firm initiated
- Recall initiated
- May 9, 2023
- Terminated
- March 14, 2024
Related products
- Heparin Sodium in Dextrose – drug information
- NDC 0264-9587 Heparin Sodium in Dextrose · Heparin Sodium 10000 [USP'U]/100mL; Dextrose Monohydrate 5… · B. Braun Medical Inc.
- NDC 0264-9577 Heparin Sodium in Dextrose · Heparin Sodium 5000 [USP'U]/100mL; Dextrose Monohydrate 5… · B. Braun Medical Inc.
- NDC 0264-9567 Heparin Sodium in Dextrose · Heparin Sodium 4000 [USP'U]/100mL; Dextrose Monohydrate 5… · B. Braun Medical Inc.